臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 50687477 線上人數 : 272 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"puri t"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 11-17 / 17 (共1頁)
1
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-05-26T09:26:44Z	Randomized phase II trial of gefitinib with and without pemetrexed as first-line therapy in patients with advanced nonsquamous non-small-cell lung cancer with activating epidermal growth factor receptor mutations	Chih-Hsin Yang;Orlando M;Puri T;Enatsu S;Wang X;Kim J.-H;Kang J.H;Nakagawa K;He J;Yang P.-C;Murakami H;Cheng Y; Cheng Y; Murakami H; Yang P.-C; He J; Nakagawa K; Kang J.H; Kim J.-H; Wang X; Enatsu S; Puri T; Orlando M; CHIH-HSIN YANG
臺大學術典藏	2020-05-26T09:26:39Z	Reply to A. Ota et al, Y.H. Kim, and N. Van Der Steen et al	Chih-Hsin Yang;Puri T;Orlando M;Cheng Y.; CHIH-HSIN YANG; Puri T; Orlando M; Cheng Y.
臺大學術典藏	2020-05-26T09:26:39Z	Reply to A. Ota et al, Y.H. Kim, and N. Van Der Steen et al	Chih-Hsin Yang;Puri T;Orlando M;Cheng Y.; CHIH-HSIN YANG; Puri T; Orlando M; Cheng Y.
臺大學術典藏	2020-05-26T09:26:33Z	A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non?�Small-Cell Lung Cancer	Park K.;Puri T;Orlando M;Han B;Mok T;Chih-Hsin Yang; CHIH-HSIN YANG; Mok T; Han B; Orlando M; Puri T; Park K.
臺大學術典藏	2020-05-26T09:26:33Z	A Review of Regimens Combining Pemetrexed With an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in the Treatment of Advanced Nonsquamous Non?�Small-Cell Lung Cancer	Park K.;Puri T;Orlando M;Han B;Mok T;Chih-Hsin Yang; CHIH-HSIN YANG; Mok T; Han B; Orlando M; Puri T; Park K.
臺大學術典藏	2020-05-25T07:35:18Z	Gefitinib maintenance therapy versus gefitinib monotherapy in east asian never-smoker patients with locally advanced or metastatic nonsquamous non-small cell lung cancer: Final overall survival results from a randomized phase 3 study	Wang X; Park K.; Yang J.C.-H; Srimuninnimit V; Ahn M.-J; Chia-Chi Lin; Kim S.-W; Tsai C.-M; Mok T; Orlando M; Puri T
臺大學術典藏	2020-05-25T02:45:31Z	An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non�Vsmall cell lung cancer	Wang L; Wu Y.-L; Lu S; Deng L; Ahn M.-J; Feng-Ming Hsu; Iscoe N; Hossain A; Puri T; Zhang P; Orlando M.

顯示項目 11-17 / 17 (共1頁)
1
每頁顯示[10|25|50]項目